• ucsantabarbara twitter avatar
    A new construction project on campus aims to ‘pave’ the way for updated utilities & better infrastructure at #UCSB. https://t.co/FkRmgpo8LC
    3 hours 48 min ago
  • UCSBgauchos twitter avatar
    WWP: Gauchos End The Day With A Dominate Win And A Close Loss https://t.co/U0mHxrjEPb
    1 day 1 hour ago
  • UCSBgauchos twitter avatar
    WBB: Gauchos Share The Cape In All-Around 74-62 Win Over Hawai'i On Super Hero Night https://t.co/7JozUy4Wi1
    1 day 2 hours ago
  • UCSBgauchos twitter avatar
    Vincent Hits 1,000 Point Mark But UCSB Loses at UC Riverside, 65-55 https://t.co/rvtR2CFZwU
    1 day 3 hours ago
  • ArtsandLectures twitter avatar
    Tune in to @prairie_home to hear @odonovanaoife & pals performing songs from #lalaland! Now on KCLU
    1 day 4 hours ago
  • UCSBgauchos twitter avatar
    WBB: FINAL UCSB 74 - Hawaii 62 Gauchos rack up season-best 4th straight win, improve to 9-9 (4-1). Edelman 19pts 6reb, Toler 17pts off bench
    1 day 4 hours ago
  • UCSBgauchos twitter avatar
    WBB: We're inside the last minute of regulation, Toler with 10 points in the final quarter. 71-60 UCSB 46.1 remaining.
    1 day 4 hours ago
  • UCSBgauchos twitter avatar
    WBB: Gauchos roar off the first 8pts and Hawaii needs to talk about it! 58-45 UCSB 7:54 remaining in the fourth quarter.
    1 day 5 hours ago
  • UCSBgauchos twitter avatar
    WBB: End of Third Quarter UCSB 50 - Hawaii 45 Hernandez goes for 8pts in 3Q. Gaucho pep band is ready for the fourt… https://t.co/VDP5Er1MZ1
    1 day 5 hours ago
  • UCSBgauchos twitter avatar
    WBB: Gauchos respond to a mini Hawaii run with a Durr and-one, and back-to-back 3's from Hernandez. 45-37 UCSB 4:56 left in 3Q.
    1 day 5 hours ago
  • UCSBgauchos twitter avatar
    WBB: Halftime UCSB 31 - Hawaii 26 Edelman with team highs 10pts and 3rebs. Gauchos a 14-8 pts in paint advantage, 11-2 off turnovers.
    1 day 5 hours ago
  • UCSBgauchos twitter avatar
    WBB: Toler with an emphatic chase down block from behind! She has first 2 buckets for UCSB in 2Q. 27-19 Gauchos, 4:21 before halftime.
    1 day 5 hours ago
  • UCSBgauchos twitter avatar
    WBB: End of First Quarter UCSB 23 - Hawaii 15. Porter leads all scorers with 9pts, 3/4 from downtown. Gauchos 11pts from 5 Hawaii turnovers.
    1 day 6 hours ago
  • UCSBgauchos twitter avatar
    WBB: Gauchos sink their first 4 from the field, 3/3 from downtown and lead 18-9 at 1Q media break. Porter 2/2 for trey, Edelman doing work.
    1 day 6 hours ago
  • brenucsb twitter avatar
    Growing an interest in nature: #UCSB students & Edible Campus Project plant seeds of sustainability in preschoolers https://t.co/dyoiFtroWo
    1 day 11 hours ago

Mouse Models Point To A Potential Therapeutic Approach for Alzheimer's

The findings demonstrate a new potential target in the fight against Alzheimer’s and other neurodegenerative diseases
Wednesday, June 26, 2013 - 17:00
Santa Barbara, CA

Tau Zhang.jpg

Neurofibrillary tangles

Neurofibrillary tangles, immunostained bright red in pyramidal neurons here, are one of the hallmarks of Alzheimer’s disease.

Photo Credit: 

Israel Hernandez, UCSB

Ken Kosik.jpeg

Kenneth S. Kosik

Kenneth S. Kosik

Kosik researchers.jpg

Hernandez and Zhang

Israel Hernandez and Xuemei Zhang

Photo Credit: 

George Foulsham

Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.

The results were published online June 4 as the Paper of the Week in the Journal of Biological Chemistry. As a Paper of the Week, Kosik's work is among the top 2 percent of manuscripts the journal reviews in a year. Based on significance and overall importance, between 50 and 100 papers are selected for this honor from the more than 6,600 published each year.

Kosik and his research team focused on tau, a protein normally present in the brain, which can develop into neurofibrillary tangles (NFTs) that, along with plaques containing amyloid-ß protein, characterize Alzheimer's disease. When tau becomes pathological, many phosphate groups attach to it, causing it to become dysfunctional and intensely phosphorylated, or hyperphosphorylated. Aggregations of hyperphosphorylated tau are also referred to as paired helical filaments.

"What struck me most while working on this project was how so many people I'd never met came to me to share their stories and personal anxieties about Alzheimer's disease," said Xuemei Zhang, lead co-author and an assistant specialist in the Kosik Lab. "There is no doubt that finding therapeutic treatment is the only way to help this fast-growing population." Israel Hernandez, a postdoctoral scholar of the NRI and UCSB's Department of Molecular, Cellular and Developmental Biology, is the paper's other lead co-author.

Treatments for hyperphosphorylated tau, one of the main causes of Alzheimer's disease, do not exist. Current treatment is restricted to drugs that increase the concentration of neurotransmitters to promote signaling between neurons.

However, this latest research explores the possibility that a small class of molecules called diaminothiazoles can act as inhibitors of kinase enzymes that phosphorylate tau. Kosik's team studied the toxicity and immunoreactivity of several diaminothiazoles that targeted two key kinases, CDK5/p25 and GSK3ß, in two Alzheimer's disease mouse models. The investigators found that the compounds can efficiently inhibit the enzymes with hardly any toxic effects in the therapeutic dose range.

Treatment with the lead compound in this study, LDN-193594, dramatically affected the prominent neuronal cell loss that accompanies increased CDK5 activity. Diaminothiazole kinase inhibitors not only reduced tau phosphorylation but also exerted a neuroprotective effect in vivo. In addition to reducing the amount of the paired helical filaments in the mice's brains, they also restored their learning and memory abilities during a fear-conditioning assay.

According to the authors, the fact that treatment with diaminothiazole kinase inhibitors reduced the phosphorylation of tau provides strong evidence that small molecular kinase inhibitor treatment could slow the progression of tau pathology. "Given the contribution of both CDK5 and GSK3ß to tau phosphorylation," said Kosik, "effective treatment of tauopathies may require dual kinase targeting."

Madison Cornwell, a Beckman Scholar with UCSB's Center for Science and Engineering Partnerships who worked in Kosik's lab, added: "As a beginning step, we demonstrated that two of these compounds were successful in clearing the brain of tau tangles in a mouse model, but someday inhibitors of these kinases may serve to ameliorate the symptoms of Alzheimer's disease in patients."

Neuroscience Research Institute

Contact Info: 

Julie Cohen julie.cohen@ia.ucsb.edu (805 893-7220

Topics: